CD8A and neoplasm: The hot tumors with high immune infiltration, particularly for CD8+ T cells, usually are sensitive to immunotherapy because the pre-stored immune cells can effectively attack tumor cells following immunotherapy, such as checkpoint inhibitors (Ochoa de Olza et al., 2020; Too et al., 2021).